Literature DB >> 1344311

Cell transplantation for myocardial repair: an experimental approach.

D Marelli1, C Desrosiers, M el-Alfy, R L Kao, R C Chiu.   

Abstract

Myocardium lacks the ability to regenerate following injury. This is in contrast to skeletal muscle (SKM), in which capacity for tissue repair is attributed to the presence of satellite cells. It was hypothesized that SKM satellite cells multiplied in vitro could be used to repair injured heart muscle. Fourteen dogs underwent explantation of the anterior tibialis muscle. Satellite cells were multiplied in vitro and their nuclei were labeled with tritiated thymidine 24 h prior to implantation. The same dogs were then subjected successfully to a myocardial injury by the application of a cryoprobe. The cells were suspended in serum-free growth medium and autotransplanted within the damaged muscle. Medium without cells was injected into an adjacent site to serve as a control. Endpoints comprised histology using standard stains as well as Masson trichrome (specific for connective tissue), and radioautography. In five dogs, satellite cell isolation, culture, and implantation were technically satisfactory. In three implanted dogs, specimens were taken within 6-8 wk. There were persistence of the implantation channels in the experimental sites when compared to the controls. Macroscopically, muscle tissue completely surrounded by scar tissue could be seen. Masson trichrome staining showed homogeneous scar in the control site, but not in the test site where a patch of muscle fibres containing intercalated discs (characteristic of myocardial tissue) was observed. In two other dogs, specimens were taken at 14 wk postimplantation. Muscle tissue could not be found. These preliminary results could be consistent with the hypothesis that SKM satellite cells can form neo-myocardium within an appropriate environment. Our specimens failed to demonstrate the presence of myocyte nuclei.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1344311     DOI: 10.1177/096368979200100602

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  26 in total

Review 1.  Current clinical perspectives on myocardial angiogenesis.

Authors:  Debabrata Mukherjee
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

2.  Stem cells to repair the broken heart: much ado about nothing?

Authors:  M Saha; R Zbinden; S R Redwood; M S Marber
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

Review 3.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

4.  From "spongy" and "cold" hearts to cellular cardiomyoplasty: tales of Canadian contribution to global cardiac surgery.

Authors:  Ray C-J Chiu
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

5.  The real estate of myoblast cardiac transplantation: negative remodeling is associated with location.

Authors:  Jonathan D McCue; Cory Swingen; Tanya Feldberg; Gabe Caron; Adam Kolb; Christopher Denucci; Somnath Prabhu; Randy Motilall; Brian Breviu; Doris A Taylor
Journal:  J Heart Lung Transplant       Date:  2008-01       Impact factor: 10.247

Review 6.  Systems approaches to preventing transplanted cell death in cardiac repair.

Authors:  Thomas E Robey; Mark K Saiget; Hans Reinecke; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

Review 7.  Current status of myocardial regeneration therapy.

Authors:  Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-07

Review 8.  Characterizing functional stem cell-cardiomyocyte interactions.

Authors:  Nenad Bursac; Robert D Kirkton; Luke C McSpadden; Brian Liau
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 9.  Bioengineering methods for myocardial regeneration.

Authors:  Hesam Parsa; Kacey Ronaldson; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2015-07-04       Impact factor: 15.470

Review 10.  Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells.

Authors:  P Sreejit; R S Verma
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.